NI
TMO icon

Nuance Investments’s Thermo Fisher Scientific TMO Stock Holding History

Nuance Investments’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9M Buy
35,664
+5,343
+18% +$2.56M 3.04% 10
2026
Q1 		$14.9M Buy
30,321
+9,311
+44% +$5.05M 2.08% 16
2025
Q4 		$12.2M Sell
21,010
-31,987
-60% -$18.1M 1.34% 20
2025
Q3 		$25.7M Sell
52,997
-34,898
-40% -$16.2M 2.62% 13
2025
Q2 		$35.6M Buy
87,895
+81,313
+1,235% +$34M 2.78% 15
2025
Q1 		$3.28M Sell
6,582
-1,428
-18% -$773K 0.22% 46
2024
Q4 		$4.17M Buy
8,010
+610
+8% +$335K 0.17% 52
2024
Q3 		$4.58M Sell
7,400
-5,450
-42% -$3.23M 0.15% 47
2024
Q2 		$7.11M Sell
12,850
-5,593
-30% -$3.2M 0.22% 47
2024
Q1 		$10.7M Sell
18,443
-146
-0.8% -$81.9K 0.28% 47
2023
Q4 		$9.87M Buy
+18,589
New +$9M 0.23% 45

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Nuance Investments's TMO Position: Q2 2026 in Review

Nuance Investments increased its Thermo Fisher Scientific (TMO) stake by 18% in Q2 2026, buying an estimated $2.56M and bringing the position to 35,664 shares worth $17.9M. The position accounts for 3.04% of the portfolio, ranked #10.

Nuance Investments first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. The position peaked at $35.6M in Q2 2025. 2,617 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Nuance Investments held 35,664 shares of Thermo Fisher Scientific worth $17.9M as of Q2 2026.
  • Nuance Investments bought 5,343 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.56M.
  • Thermo Fisher Scientific made up 3.04% of Nuance Investments's portfolio in Q2 2026, its #10 holding.
  • Nuance Investments first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • Nuance Investments's Thermo Fisher Scientific position peaked at $35.6M in Q2 2025.
  • 2,617 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nuance Investments's 13F filing for Q2 2026, filed 7 Aug 2026.